Factors that may complicate the evaluation of PD-L1 in NSCLC NCBs, such as tumor necrosis, tumor-infiltrating lymphocytes, tumor length and percentage in the biopsy, and effect of crush/squeeze artifact have not been evaluated before. This evidence concerns the gene CD274 and non-small cell lung carcinoma.